Project Grant HT94252510499
Award Date
7/1/25
Completion Date
6/30/29
Dollars Obligated
$1.2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
The University of Pennsylvania received a $2,060,500 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to conduct research on "VALIDATION OF NOVEL DRIVERS OF JUVENILE POLYPOSIS SYNDROME". The award period is from September 1, 2023 to August 31, 2027. Through this Project Grant, the University of Pennsylvania will perform biomedical research to investigate innovative solutions for healthcare challenges facing U.S. service...
The federal Formula Grant award in the amount of $390,000.00, awarded by the Defense Health Agency on March 15, 2025, supports a research project titled "EXPLOITING SYNTHETIC ESSENTIAL GENETIC DEPENDENCIES TO DEFINE ONCOGENIC SIGNALING NETWORKS AND ESTABLISH NOVEL TARGETS FOR LUNG ADENOCARCINOMA THERAPY" under the Military Medical Research and Development (CFDA 12.420) program. The award is granted to The Trustees of the University of Pennsylvania, doing business as Clinical...
The Trustees of the University of Pennsylvania will receive $975,000 through a three-year Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support lung cancer research from July 1, 2023 to June 30, 2026. Through this funding, the University and its Clinical Practices will conduct biomedical research to transform service member healthcare and investigate medical solutions applicable to battlefield medicine....
The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $325,000 project grant to The Trustees of the University of Pennsylvania (Penn) to develop a PET agent, (18F-THA), for studying the central and intestinal lymphatic system. The 2-year project, with a performance period from April 15, 2024 to April 14, 2026, aims to advance research on the lymphatic system, which is relevant to military medical priorities. As a renowned research...
The Trustees of the University of Pennsylvania were awarded a $299,099 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research into Metabolic Target Identification in Age-Associated B Cells from May 1, 2023 through April 30, 2025. As part of the Military Medical Research and Development program's goals of transforming military and public health care through innovative medical research, this...
This federal Project Grant award for $5,238,417.00, granted by the Department of Defense's Military Medical Research and Development program (CFDA 12.420), funds a multi-year research project titled "OPTIMIZING A SURVEILLANCE STRATEGY TO TACKLE BREAST CANCER DORMANCY AND MINIMAL RESIDUAL DISEASE". The award was made on Sep 15, 2023 to The Trustees Of The University Of Pennsylvania, with an ultimate completion date of Sep 14, 2027. A key sub-award was made to Trustees Of Indiana...
This federal Project Grant award in the amount of $1,605,638.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant was awarded to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, a private research university and academic medical center. The grant funding supports research aimed at developing new methods for immune targeting of dormant tumor...
This $2,905,936 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports a pilot randomized clinical trial of early ventilation in amyotrophic lateral sclerosis (ALS) conducted by The Trustees of the University of Pennsylvania. The study aims to transform healthcare for military service members and the public by investigating innovative approaches to prevent, diagnose, and manage medical conditions relevant to...
This $819,195 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by Drexel University on the PEDF PLXDC1 ADNP signaling pathways related to neuromorphogenesis and neural circuit development. The award, which runs from September 15, 2023 to September 14, 2026, will fund basic, translational, and clinical research aimed at advancing scientific understanding and developing new treatments in areas such as...
The U.S. Department of Defense's Defense Health Agency has awarded a $1,255,505 Project Grant to Pennsylvania State University, doing business as Penn State Milton S. Hershey Medical Center, under the Military Medical Research and Development program (CFDA 12.420). The grant, which has a performance period of July 1, 2024 to June 30, 2027, is for the development of a unique small molecule for the treatment of triple-negative breast cancer. As a leading academic medical center, Penn State has...